Total amount raised
$134 Millions
Latest funding date
11/1/2023
Location
Click Therapeutics has successfully raised significant funding through multiple rounds, with strategic investments from notable entities like Dassault Systèmes and Medidata. Their innovative platform combines neuroscience and software to create digital treatments that address unmet medical needs.
Keep reading to explore the intricacies of Click Therapeutics' fundraising journey and the investors backing this pioneering platform.
What Is Click Therapeutics?
Click Therapeutics, founded by David Benshoof Klein, is a pioneering company in the digital health space. They specialize in developing software as prescription medical treatments, combining neuroscience with software to address unmet medical needs.
Based in New York, Click Therapeutics has been redefining modern medicine with their innovative approach. Their platform focuses on creating patient-centric digital treatments that can be prescribed by physicians and delivered directly to patients' phones.
With a dedicated team, Click Therapeutics continues to push the boundaries of traditional healthcare, aiming to provide effective and accessible treatments for various conditions.
How Much Funding Has Click Therapeutics Raised?
- Funding Round
- Amount Raised: $3M
- Date: November 2018
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support early-stage development and operational costs.
- Series A
- Amount Raised: $19M
- Date: October 2018
- Lead Investors: Sanofi Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To accelerate product development and expand the team.
- Convertible Note
- Amount Raised: $3.7M
- Date: April 2017
- Lead Investors: Magellan Health Services
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To fund ongoing research and development efforts.
- Corporate Round
- Amount Raised: $500M
- Date: September 2020
- Lead Investors: Boehringer Ingelheim
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale operations and expand market reach.
- Debt Financing
- Amount Raised: $30M
- Date: December 2020
- Lead Investors: K2 HealthVentures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support clinical trials and regulatory submissions.
- Series B
- Amount Raised: $52M
- Date: October 2021
- Lead Investors: Accelmed, H.I.G. BioHealth Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand product pipeline and enhance technological capabilities.
- Debt Financing
- Amount Raised: $15M
- Date: April 2022
- Lead Investors: Silicon Valley Bank
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To fund ongoing product development and market expansion.
- Debt Financing
- Amount Raised: $20M
- Date: November 2023
- Lead Investors: HSBC Innovation Banking
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support scaling operations and entering new markets.
- Debt Financing
- Amount Raised: $8.3M
- Date: November 2024
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To enhance technological infrastructure and support product launches.
- Funding Round
- Amount Raised: $3M
- Date: November 2024
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To fund new research initiatives and expand the team.
Total Amount Raised: $650M. Current Valuation: Not publicly disclosed.
Key Investors
- Boehringer Ingelheim
- Details: Boehringer Ingelheim is a global pharmaceutical company headquartered in Germany. It focuses on researching, developing, and manufacturing innovative healthcare solutions.
- Investment Focus Areas: Pharmaceuticals, animal health, biopharmaceuticals.
- Notable Investments: Ofev, Jardiance, Spiriva.
- Sanofi Ventures
- Details: Sanofi Ventures is the venture capital arm of Sanofi, a global healthcare leader. They invest in early-stage companies with innovative healthcare solutions.
- Investment Focus Areas: Biotechnology, digital health, medical devices.
- Notable Investments: Amunix, Kiadis Pharma, Inozyme Pharma.
- Accelmed
- Details: Accelmed is a private equity firm focused on medical device and healthcare IT companies. They aim to accelerate growth and innovation in the healthcare sector.
- Investment Focus Areas: Medical devices, healthcare IT, diagnostics.
- Notable Investments: Keystone Dental, TearLab, Cogentix Medical.
- H.I.G. BioHealth Partners
- Details: H.I.G. BioHealth Partners is a venture capital firm that invests in life sciences companies. They focus on companies with transformative healthcare technologies.
- Investment Focus Areas: Biotechnology, medical devices, diagnostics.
- Notable Investments: Alder Biopharmaceuticals, CardioFocus, VertiFlex.
- HSBC Innovation Banking
- Details: HSBC Innovation Banking provides financial services to high-growth technology and life sciences companies. They support companies through various stages of growth.
- Investment Focus Areas: Technology, life sciences, healthcare.
- Notable Investments: Not publicly disclosed.
What's Next for Click Therapeutics?
Click Therapeutics stands at the cusp of a significant opportunity with its diverse pipeline targeting conditions like Major Depressive Disorder, Type 2 Diabetes, and Schizophrenia. The potential market for these digital therapeutics is vast, given the millions affected by these conditions globally. As the industry trends towards personalized, patient-centric treatments, Click Therapeutics is well-positioned to capitalize on this shift.
Future fundraising efforts will likely focus on advancing clinical trials and securing regulatory approvals. With a strong track record of attracting investment, the company is poised to continue its growth trajectory. However, challenges such as navigating regulatory landscapes and ensuring patient engagement with digital solutions remain. Overcoming these hurdles will be crucial for sustained success.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like Click Therapeutics and gather other critical business insights.
Sign up for free on Clay and start making data-driven decisions today.
